FDA Inspection
Octapharma ABOctapharma AB – FDA Inspection, Jan 20, 2011
Record Details
This FDA Inspection record concerns Octapharma AB, with an inspection on January 20, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma AB
- Inspection Date
- January 20, 2011
- Product Type
- Biologics
View Company Profile
ID · e46fa3b2-794a-456e-97d5-2b973b8e1194
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 710676
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Octapharma AB
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 28, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 3, 2016 | Not classified | Office of Inspections and Investigations | |
| April 28, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma AB
- FDA Inspection 1218250 - 2023-09-19
- FDA Inspection 1070173 - 2018-09-28
- FDA Inspection 994537 - 2016-10-03
- FDA Inspection 894095 - 2014-04-28
- FDA Inspection 783783 - 2012-01-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.